bioAffinity Technologies, Inc. Profile Avatar - Palmy Investing

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targe…

Medical - Diagnostics & Research
US, San Antonio [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of BIAF's Analysis
CIK: 1712762 CUSIP: 09076W109 ISIN: US09076W1099 LEI: - UEI: -
Secondary Listings
BIAF has no secondary listings inside our databases.